Helge Hasselmann

There are 23 results.

Helge is a psychologist turned clinical neuroscientist whose special interests lie with affective disorders and psychopharmacology. While not based on personal experience, he has a hunch that ketamine may be the next blockbuster drug.

All Posts by Helge Hasselmann

Antidepressants for depression: new BAP guidance
21 Sep 2015
- Helge Hasselmann
The antidepressant effects of ketamine are confirmed by a new systematic review and meta-analysis
10 Apr 2015
- Helge Hasselmann
Poor oral health and severe mental illness: what are the links?
16 Mar 2015
- Helge Hasselmann
We don’t know how to improve medicine adherence, says new Cochrane review
26 Jan 2015
- Helge Hasselmann
Anti-inflammatory drugs for depression: new review points to benefits, but more research needed
28 Nov 2014
- Helge Hasselmann
Does depression make us lethargic, or does lack of exercise make us depressed?
11 Nov 2014
- Helge Hasselmann
Tricyclic antidepressants for ADHD in children and adolescents: Cochrane review finds no evidence to support prescribing
16 Oct 2014
- Helge Hasselmann
Ketamine for depression: new review highlights the need for an RCT
08 Sep 2014
- Helge Hasselmann
The adverse effects of psychiatric drugs and emergency department visits
22 Jul 2014
- Helge Hasselmann
Spoilt for choice? Four new Cochrane reviews on antipsychotics for schizophrenia
23 May 2014
- Helge Hasselmann